Understanding the pathophysiology of the human TB lung granuloma using in vitro granuloma models

Papers of special note have been highlighted as: • of interest

References

• 1 WHO. www.who.int/tb/country/en/
  Google Scholar
• 2 de Jong BC, Adetifa I, Walther B et al. Differences between tuberculosis cases infected with Mycobacterium africanum, west African type 2, relative to Euro-American Mycobacterium tuberculosis: an update. FEMS Immunol. Med. Microbiol. 58(1), 102–105 (2010).
  Medline CASGoogle Scholar
• 3 de Jong BC, Antonio M, Gagneux S. Mycobacterium africanum – review of an important cause of human tuberculosis in West Africa. PLoS Negl. Trop. Dis. 4(9), e744 (2010).
  MedlineGoogle Scholar
• 4 Gong C, Linderman JJ, Kirschner D. A population model capturing dynamics of tuberculosis granulomas predicts host infection outcomes. Math. Biosci. Eng. 12(3), 625–642 (2015).
  MedlineGoogle Scholar
• 5 Corbett EL, Watt CJ, Walker N et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163(9), 1009–1021 (2003).
  MedlineGoogle Scholar
• 6 Zumla A, Nahid P, Cole ST. Advances in the development of new tuberculosis drugs and treatment regimens. Nat. Rev. Drug Discov. 12(5), 388–404 (2013).
  Medline CASGoogle Scholar
• 7 Zumla A, Chakaya J, Centis R et al. Tuberculosis treatment and management – an update on treatment regimens, trials, new drugs, and adjunct therapies. Lancet Respir. Med. 3(3), 220–234 (2015).
  MedlineGoogle Scholar
• 8 Mdluli K, Kaneko T, Upton A. The tuberculosis drug discovery and development pipeline and emerging drug targets. Cold Spring Harb. Perspect. Med. 5(6), 10.1101/cshperspect.a021154 (2015).
  MedlineGoogle Scholar
• 9 Ernst JD. The immunological life cycle of tuberculosis. Nat. Rev. Immunol. 12(8), 581–591 (2012).
  Medline CASGoogle Scholar
• 10 van Crevel R, Ottenhoff TH, van der Meer JW. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15(2), 294–309 (2002).
  Medline CASGoogle Scholar
• 11 Warner DF, Koch A, Mizrahi V. Diversity and disease pathogenesis in Mycobacterium tuberculosis. Trends Microbiol. 23(1), 14–21 (2015).
  Medline CASGoogle Scholar
• 12 Gold MC, Cerri S, Smyk-Pearson S et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 8(6), e1000407 (2010).
  MedlineGoogle Scholar
• 13 Cambier CJ, Takaki KK, Larson RP et al. Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 505(7482), 218–222 (2014).
  Medline CASGoogle Scholar
• 14 Ernst JD. Macrophage receptors for Mycobacterium tuberculosis. Infect. Immun. 66(4), 1277–1281 (1998).
  Medline CASGoogle Scholar
• 15 Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593–623 (1999).
  Medline CASGoogle Scholar
• 16 Leemans JC, Florquin S, Heikens M, Pals ST, van der Neut R, Van Der Poll T. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis. J. Clin. Invest. 111(5), 681–689 (2003).
  Medline CASGoogle Scholar
• 17 Ferrari G, Langen H, Naito M, Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97(4), 435–447 (1999).
  Medline CASGoogle Scholar
• 18 Glickman MS, Jacobs WR Jr. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 104(4), 477–485 (2001).
  Medline CASGoogle Scholar
• 19 Gonzalez-Juarrero M, Orme IM. Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect. Immun. 69(2), 1127–1133 (2001).
  Medline CASGoogle Scholar
• 20 Wolf AJ, Linas B, Trevejo-Nunez GJ et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol. 179(4), 2509–2519 (2007).
  Medline CASGoogle Scholar
• 21 Skold M, Behar SM. Tuberculosis triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J. Immunol. 181(9), 6349–6360 (2008).
  MedlineGoogle Scholar
• 22 Flynn JL, Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93–129 (2001).
  Medline CASGoogle Scholar
• 23 Birkness KA, Guarner J, Sable SB et al. An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection. Immunol. Cell Biol. 85(2), 160–168 (2007).
  Medline CASGoogle Scholar
• 24 Kaku T, Kawamura I, Uchiyama R, Kurenuma T, Mitsuyama M. RD1 region in mycobacterial genome is involved in the induction of necrosis in infected RAW264 cells via mitochondrial membrane damage and ATP depletion. FEMS Microbiol. Lett. 274(2), 189–195 (2007).
  Medline CASGoogle Scholar
• 25 Khader SA, Partida-Sanchez S, Bell G et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. J. Exp. Med. 203(7), 1805–1815 (2006).
  Medline CASGoogle Scholar
• 26 Robinson RT, Khader SA, Martino CA et al. Mycobacterium tuberculosis infection induces il12rb1 splicing to generate a novel IL-12Rbeta1 isoform that enhances DC migration. J. Exp. Med. 207(3), 591–605 (2010).
  Medline CASGoogle Scholar
• 27 Samstein M, Schreiber HA, Leiner IM, Susac B, Glickman MS, Pamer EG. Essential yet limited role for CCR2(+) inflammatory monocytes during Mycobacterium tuberculosis-specific T cell priming. Elife 2, e01086 (2013).
  MedlineGoogle Scholar
• 28 Orme IM, Basaraba RJ. The formation of the granuloma in tuberculosis infection. Semin. Immunol. 26(6), 601–609 (2014).
  MedlineGoogle Scholar
• 29 Ehlers S, Schaible UE. The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front. Immunol. 3, 411 (2013).
  MedlineGoogle Scholar
• 30 Reece ST, Kaufmann SH. Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis? Curr. Opin. Microbiol. 15(1), 63–70 (2012).
  MedlineGoogle Scholar
• 31 Gengenbacher M, Kaufmann SH. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol. Rev. 36(3), 514–532 (2012).
  Medline CASGoogle Scholar
• 32 Guirado E, Schlesinger LS. Modeling the Mycobacterium tuberculosis granuloma – the critical battlefield in host immunity and disease. Front. Immunol. 4, 98 (2013).
  MedlineGoogle Scholar
• 33 Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, Flynn JL. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162(9), 5407–5416 (1999).
  Medline CASGoogle Scholar
• 34 Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat. Immunol. 10(9), 943–948 (2009).
  Medline CASGoogle Scholar
• 35 Ladel CH, Daugelat S, Kaufmann SH. Immune response to Mycobacterium bovis Bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance. Eur. J. Immunol. 25(2), 377–384 (1995).
  Medline CASGoogle Scholar
• 36 Ladel CH, Blum C, Dreher A, Reifenberg K, Kaufmann SH. Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur. J. Immunol. 25(10), 2877–2881 (1995).
  Medline CASGoogle Scholar
• 37 Ladel CH, Hess J, Daugelat S, Mombaerts P, Tonegawa S, Kaufmann SH. Contribution of alpha/beta and gamma/delta T lymphocytes to immunity against Mycobacterium bovis Bacillus Calmette Guerin: studies with T cell receptor-deficient mutant mice. Eur. J. Immunol. 25(3), 838–846 (1995).
  Medline CASGoogle Scholar
• 38 Flynn JL, Goldstein MM, Triebold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. USA 89(24), 12013–12017 (1992).
  Medline CASGoogle Scholar
• 39 Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193(3), 271–280 (2001).
  Medline CASGoogle Scholar
• 40 Apostolou I, Takahama Y, Belmant C et al. Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc. Natl Acad. Sci. USA 96(9), 5141–5146 (1999).
  Medline CASGoogle Scholar
• 41 Sugawara I, Yamada H, Mizuno S, Li CY, Nakayama T, Taniguchi M. Mycobacterial infection in natural killer T cell knockout mice. Tuberculosis (Edinb.) 82(2–3), 97–104 (2002).
  Medline CASGoogle Scholar
• 42 Juffermans NP, Florquin S, Camoglio L et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J. Infect. Dis. 182(3), 902–908 (2000).
  Medline CASGoogle Scholar
• 43 Yamada H, Mizumo S, Horai R, Iwakura Y, Sugawara I. Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice. Lab. Invest. 80(5), 759–767 (2000).
  Medline CASGoogle Scholar
• 44 Altare F, Ensser A, Breiman A et al. Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis. J. Infect. Dis. 184(2), 231–236 (2001).
  Medline CASGoogle Scholar
• 45 Gideon HP, Phuah J, Myers AJ et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog. 11(1), e1004603 (2015).
  MedlineGoogle Scholar
• 46 Khader SA, Pearl JE, Sakamoto K et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175(2), 788–795 (2005).
  Medline CASGoogle Scholar
• 47 Powrie F, Coffman RL. Inhibition of cell-mediated immunity by IL4 and IL10. Res. Immunol. 144(8), 639–643 (1993).
  Medline CASGoogle Scholar
• 48 Bonecini-Almeida MG, Ho JL, Boechat N et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect. Immun. 72(5), 2628–2634 (2004).
  Medline CASGoogle Scholar
• 49 Remus N, Reichenbach J, Picard C et al. Impaired interferon gamma-mediated immunity and susceptibility to mycobacterial infection in childhood. Pediatr. Res. 50(1), 8–13 (2001).
  Medline CASGoogle Scholar
• 50 Fieschi C, Casanova JL. The role of interleukin-12 in human infectious diseases: only a faint signature. Eur. J. Immunol. 33(6), 1461–1464 (2003).
  Medline CASGoogle Scholar
• 51 Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186(1), 39–45 (1997).
  Medline CASGoogle Scholar
• 52 van de Vosse E, de Paus RA, van Dissel JT, Ottenhoff TH. Molecular complementation of IL-12Rbeta1 deficiency reveals functional differences between IL-12Rbeta1 alleles including partial IL-12Rbeta1 deficiency. Hum. Mol. Genet. 14(24), 3847–3855 (2005).
  Medline CASGoogle Scholar
• 53 Lin Y, Zhang M, Barnes PF. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 66(3), 1121–1126 (1998).
  Medline CASGoogle Scholar
• 54 Wickremasinghe MI, Thomas LH, Friedland JS. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. J. Immunol. 163(7), 3936–3947 (1999).
  Medline CASGoogle Scholar
• 55 Khader SA, Rangel-Moreno J, Fountain JJ et al. In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J. Immunol. 183(12), 8004–8014 (2009).
  Medline CASGoogle Scholar
• 56 Khader SA, Guglani L, Rangel-Moreno J et al. IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J. Immunol. 187(10), 5402–5407 (2011).
  Medline CASGoogle Scholar
• 57 Slight SR, Rangel-Moreno J, Gopal R et al. CXCR5(+) T helper cells mediate protective immunity against tuberculosis. J. Clin. Invest. 123(2), 712–726 (2013).
  Medline CASGoogle Scholar
• 58 Eum SY, Kong JH, Hong MS et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 137(1), 122–128 (2010).
  MedlineGoogle Scholar
• 59 Berry MP, Graham CM, McNab FW et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466(7309), 973–977 (2010).
  Medline CASGoogle Scholar
• 60 Chen RY, Dodd LE, Lee M et al. PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis. Sci. Transl. Med. 6(265), 265ra166 (2014).
  MedlineGoogle Scholar
• 61 Lenaerts A, Barry CE, Dartois V. Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses. Immunol. Rev. 264(1), 288–307 (2015). • Recent review that describes how the granuloma environment of Mycobacterium tuberculosis (Mtb) infection may be more heterogeneous than previously thought.
  Medline CASGoogle Scholar
• 62 Lin PL, Ford CB, Coleman MT et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat. Med. 20(1), 75–79 (2014).
  Medline CASGoogle Scholar
• 63 During A, Penel G, Hardouin P. Understanding the local actions of lipids in bone physiology. Prog. Lipid Res. 59, 126–146 (2015).
  Medline CASGoogle Scholar
• 64 Russell CD, Schwarze J. The role of pro-resolution lipid mediators in infectious disease. Immunology 141(2), 166–173 (2014).
  Medline CASGoogle Scholar
• 65 Tobin DM, Roca FJ, Ray JP, Ko DC, Ramakrishnan L. An enzyme that inactivates the inflammatory mediator leukotriene b4 restricts mycobacterial infection. PLoS ONE 8(7), e67828 (2013).
  Medline CASGoogle Scholar
• 66 Tobin DM, Ramakrishnan L. TB: the Yin and Yang of lipid mediators. Curr. Opin. Pharmacol. 13(4), 641–645 (2013).
  Medline CASGoogle Scholar
• 67 Mayer-Barber KD, Sher A. Cytokine and lipid mediator networks in tuberculosis. Immunol. Rev. 264(1), 264–275 (2015).
  Medline CASGoogle Scholar
• 68 Ehrt S, Rhee K, Schnappinger D. Mycobacterial genes essential for the pathogen's survival in the host. Immunol. Rev. 264(1), 319–326 (2015).
  Medline CASGoogle Scholar
• 69 Zheng H, Lu L, Wang B et al. Genetic basis of virulence attenuation revealed by comparative genomic analysis of Mycobacterium tuberculosis strain H37Ra versus H37Rv. PLoS ONE 3(6), e2375 (2008).
  MedlineGoogle Scholar
• 70 Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178(5), 1274–1282 (1996).
  Medline CASGoogle Scholar
• 71 Yang R, Xi C, Sita DR et al. The RD1 locus in the Mycobacterium tuberculosis genome contributes to the maturation and secretion of IL-1alpha from infected macrophages through the elevation of cytoplasmic calcium levels and calpain activation. Pathog. Dis. 70(1), 51–60 (2014).
  Medline CASGoogle Scholar
• 72 Behr MA, Wilson MA, Gill WP et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284(5419), 1520–1523 (1999).
  Medline CASGoogle Scholar
• 73 Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327(5964), 466–469 (2010).
  Medline CASGoogle Scholar
• 74 Elkington PT, Ugarte-Gil CA, Friedland JS. Matrix metalloproteinases in tuberculosis. Eur. Respir. J. 38(2), 456–464 (2011).
  Medline CASGoogle Scholar
• 75 Nouailles G, Dorhoi A, Koch M et al. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J. Clin. Invest. 124(3), 1268–1282 (2014).
  Medline CASGoogle Scholar
• 76 Taylor JL, Hattle JM, Dreitz SA et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect. Immun. 74(11), 6135–6144 (2006).
  Medline CASGoogle Scholar
• 77 Mostowy S, Cleto C, Sherman DR, Behr MA. The Mycobacterium tuberculosis complex transcriptome of attenuation. Tuberculosis (Edinb.) 84(3–4), 197–204 (2004).
  MedlineGoogle Scholar
• 78 Selvaraj P, Alagarasu K, Singh B, Afsal K. CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of south India. Int. J. Immunogenet. 38(5), 397–402 (2011).
  Medline CASGoogle Scholar
• 79 Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89(2), 207–215 (2011).
  Medline CASGoogle Scholar
• 80 Flores-Villanueva PO, Ruiz-Morales JA, Song CH et al. A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis. J. Exp. Med. 202(12), 1649–1658 (2005).
  Medline CASGoogle Scholar
• 81 Rutter JL, Mitchell TI, Buttice G et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 58(23), 5321–5325 (1998).
  Medline CASGoogle Scholar
• 82 Ganachari M, Ruiz-Morales JA, Gomez de la Torre Pretell JC, Dinh J, Granados J, Flores-Villanueva PO. Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals. PLoS ONE 5(1), e8881 (2010).
  MedlineGoogle Scholar
• 83 Loebel RO, Shorr E, Richardson HB. The influence of adverse conditions upon the respiratory metabolism and growth of human tubercle bacilli. J. Bacteriol. 26(2), 167–200 (1933).
  Medline CASGoogle Scholar
• 84 Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43(3), 717–731 (2002).
  Medline CASGoogle Scholar
• 85 Gengenbacher M, Rao SP, Pethe K, Dick T. Nutrient-starved, non-replicating Mycobacterium tuberculosis requires respiration, ATP synthase and isocitrate lyase for maintenance of ATP homeostasis and viability. Microbiology 156(Pt 1), 81–87 (2010).
  Medline CASGoogle Scholar
• 86 Rao SP, Alonso S, Rand L, Dick T, Pethe K. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 105(33), 11945–11950 (2008).
  Medline CASGoogle Scholar
• 87 Xie Z, Siddiqi N, Rubin EJ. Differential antibiotic susceptibilities of starved Mycobacterium tuberculosis isolates. Antimicrob. Agents Chemother. 49(11), 4778–4780 (2005).
  Medline CASGoogle Scholar
• 88 Yano T, Li LS, Weinstein E, Teh JS, Rubin H. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH-menaquinone oxidoreductase (NDH-2). J. Biol. Chem. 281(17), 11456–11463 (2006).
  Medline CASGoogle Scholar
• 89 Albrethsen J, Agner J, Piersma SR et al. Proteomic profiling of Mycobacterium tuberculosis identifies nutrient-starvation-responsive toxin-antitoxin systems. Mol. Cell. Proteomics 12(5), 1180–1191 (2013).
  Medline CASGoogle Scholar
• 90 Rifat D, Karakousis PC. Differential regulation of the two-component regulatory system senX3-regX3 in Mycobacterium tuberculosis. Microbiology 160(Pt 6), 1125–1133 (2014).
  Medline CASGoogle Scholar
• 91 Kjellsson MC, Via LE, Goh A et al. Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions. Antimicrob. Agents Chemother. 56(1), 446–457 (2012).
  Medline CASGoogle Scholar
• 92 Pienaar E, Cilfone NA, Lin PL et al. A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment. J. Theor. Biol. 367, 166–179 (2015).
  Medline CASGoogle Scholar
• 93 Prideaux B, Dartois V, Staab D et al. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal. Chem. 83(6), 2112–2118 (2011).
  Medline CASGoogle Scholar
• 94 Shleeva M, Kondratieva T, Rubakova E, Vostroknutova G, Kaprelyants A, Apt A. Reactivation of dormant ‘non-culturable’ Mycobacterium tuberculosis developed in vitro after injection in mice: both the dormancy depth and host genetics influence the outcome. Microb. Pathog. 78, 63–66 (2015).
  MedlineGoogle Scholar
• 95 Singh A, Sharma S. Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis. Tuberculosis (Edinb.) 94(6), 695–700 (2014).
  Medline CASGoogle Scholar
• 96 Tsai MC, Chakravarty S, Zhu G et al. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell. Microbiol. 8(2), 218–232 (2006).
  Medline CASGoogle Scholar
• 97 Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78(1), 57–66 (1997).
  Medline CASGoogle Scholar
• 98 Ulrichs T, Kaufmann SH. New insights into the function of granulomas in human tuberculosis. J. Pathol. 208(2), 261–269 (2006).
  Medline CASGoogle Scholar
• 99 Jenney CR, DeFife KM, Colton E, Anderson JM. Human monocyte/macrophage adhesion, macrophage motility, and IL-4-induced foreign body giant cell formation on silane-modified surfaces in vitro. Student Research Award in the Master's Degree Candidate Category, 24th Annual Meeting of the Society for Biomaterials, San Diego, CA, April 22–26, 1998. J. Biomed. Mater. Res. 41(2), 171–184 (1998).
  Medline CASGoogle Scholar
• 100 Fayyazi A, Eichmeyer B, Soruri A et al. Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis. J. Pathol. 191(4), 417–425 (2000).
  Medline CASGoogle Scholar
• 101 Al Shammari B, Shiomi T, Tezera L et al. The extracellular matrix regulates granuloma necrosis in tuberculosis. J. Infect. Dis. 212(3), 463–473 (2015). • This manuscript identifies the key role that an extracellular matrix plays in Mtb pathophysiology.
  Medline CASGoogle Scholar
• 102 Shi C, Shi J, Xu Z. A review of murine models of latent tuberculosis infection. Scand. J. Infect. Dis. 43(11–12), 848–856 (2011).
  Medline CASGoogle Scholar
• 103 Roh IS, Cho S, Eum SY, Cho SN. Kinetics of IFN-gamma and TNF-alpha gene expression and their relationship with disease progression after infection with Mycobacterium tuberculosis in guinea pigs. Yonsei Med. J. 54(3), 707–714 (2013).
  Medline CASGoogle Scholar
• 104 Somashekar BS, Amin AG, Rithner CD et al. Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1H magic angle spinning NMR studies. J. Proteome Res. 10(9), 4186–4195 (2011).
  Medline CASGoogle Scholar
• 105 Lu JB, Chen BW, Wang GZ et al. Recombinant tuberculosis vaccine AEC/BC02 induces antigen-specific cellular responses in mice and protects guinea pigs in a model of latent infection. J. Microbiol. Immunol. Infect. (2014).
  Google Scholar
• 106 Subbian S, Eugenin E, Kaplan G. Detection of Mycobacterium tuberculosis in latently infected lungs by immunohistochemistry and confocal microscopy. J. Med. Microbiol. 63(Pt 11), 1432–1435 (2014).
  MedlineGoogle Scholar
• 107 Subbian S, O'Brien P, Kushner NL et al. Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis. Cell. Commun. Signal. 11(1), doi:16-811X-11-16 (2013).
  Google Scholar
• 108 Flynn JL, Gideon HP, Mattila JT, Lin PL. Immunology studies in non-human primate models of tuberculosis. Immunol. Rev. 264(1), 60–73 (2015).
  Medline CASGoogle Scholar
• 109 Lin PL, Myers A, Smith L et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 62(2), 340–350 (2010).
  Medline CASGoogle Scholar
• 110 Magombedze G, Garira W, Mwenje E. Modelling the human immune response mechanisms to Mycobacterium tuberculosis infection in the lungs. Math. Biosci. Eng. 3(4), 661–682 (2006).
  MedlineGoogle Scholar
• 111 Fallahi-Sichani M, El-Kebir M, Marino S, Kirschner DE, Linderman JJ. Multiscale computational modeling reveals a critical role for TNF-alpha receptor 1 dynamics in tuberculosis granuloma formation. J. Immunol. 186(6), 3472–3483 (2011).
  Medline CASGoogle Scholar
• 112 Ray JC, Flynn JL, Kirschner DE. Synergy between individual TNF-dependent functions determines granuloma performance for controlling Mycobacterium tuberculosis infection. J. Immunol. 182(6), 3706–3717 (2009).
  Medline CASGoogle Scholar
• 113 Warrender C, Forrest S, Koster F. Modeling intercellular interactions in early Mycobacterium infection. Bull. Math. Biol. 68(8), 2233–2261 (2006).
  MedlineGoogle Scholar
• 114 Bru A, Cardona PJ. Mathematical modeling of tuberculosis bacillary counts and cellular populations in the organs of infected mice. PLoS ONE 5(9), e12985 (2010).
  MedlineGoogle Scholar
• 115 Ganguli S, Gammack D, Kirschner DE. A metapopulation model of granuloma formation in the lung during infection with Mycobacterium tuberculosis. Math. Biosci. Eng. 2(3), 535–560 (2005).
  MedlineGoogle Scholar
• 116 Marino S, El-Kebir M, Kirschner D. A hybrid multi-compartment model of granuloma formation and T cell priming in tuberculosis. J. Theor. Biol. 280(1), 50–62 (2011).
  Medline CASGoogle Scholar
• 117 Wigginton JE, Kirschner D. A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J. Immunol. 166(3), 1951–1967 (2001).
  Medline CASGoogle Scholar
• 118 Parasa VR, Rahman MJ, Ngyuen Hoang AT, Svensson M, Brighenti S, Lerm M. Modeling Mycobacterium tuberculosis early granuloma formation in experimental human lung tissue. Dis. Model. Mech. 7(2), 281–288 (2014). • Study describes the creation of an experimental lung tissue model of a Mtb granuloma. This allows for the complex modeling of infection in a 3D tissue model.
  MedlineGoogle Scholar
• 119 Nguyen Hoang AT, Chen P, Juarez J et al. Dendritic cell functional properties in a three-dimensional tissue model of human lung mucosa. Am. J. Physiol. Lung Cell. Mol. Physiol. 302(2), L226–37 (2012).
  MedlineGoogle Scholar
• 120 Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418(6894), 191–195 (2002).
  Medline CASGoogle Scholar
• 121 Guirado E, Mbawuike U, Keiser TL et al. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model. MBio 6(1), e02537-14 (2015). • Identifies how granuloma models can be used to study the impact of host and microbial factors on latency.
  Medline CASGoogle Scholar
• 122 Franklin GF, Coghill G, McIntosh L, Cree IA. Monocyte aggregation around agarose beads in collagen gels: a 3-dimensional model of early granuloma formation? J. Immunol. Methods 186(2), 285–291 (1995).
  Medline CASGoogle Scholar
• 123 Postlethwaite AE, Jackson BK, Beachey EH, Kang AH. Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes. J. Exp. Med. 155(1), 168–178 (1982).
  Medline CASGoogle Scholar
• 124 Puissegur MP, Botanch C, Duteyrat JL, Delsol G, Caratero C, Altare F. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell. Microbiol. 6(5), 423–433 (2004).
  Medline CASGoogle Scholar
• 125 Au FC, Webber B, Rosenberg SA. Pulmonary granulomas induced by BCG. Cancer 41(6), 2209–2214 (1978).
  Medline CASGoogle Scholar
• 126 Daniel J, Deb C, Dubey VS et al. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J. Bacteriol. 186(15), 5017–5030 (2004).
  Medline CASGoogle Scholar
• 127 Deb C, Lee CM, Dubey VS et al. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipid-loaded, drug-tolerant, dormant pathogen. PLoS ONE 4(6), e6077 (2009).
  MedlineGoogle Scholar
• 128 Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog. 7(6), e1002093 (2011).
  Medline CASGoogle Scholar
• 129 Seitzer U, Gerdes J. Generation and characterization of multicellular heterospheroids formed by human peripheral blood mononuclear cells. Cells Tissues Organs 174(3), 110–116 (2003).
  MedlineGoogle Scholar
• 130 Birkness KA, Guarner J, Sable SB et al. An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection. Immunol. Cell Biol. 85(2), 160–168 (2007).
  Medline CASGoogle Scholar
• 131 Kapoor N, Pawar S, Sirakova TD, Deb C, Warren WL, Kolattukudy PE. Human granuloma in vitro model, for TB dormancy and resuscitation. PLoS ONE 8(1), e53657 (2013).
  Medline CASGoogle Scholar
• 132 Wang H, Maeda Y, Fukutomi Y, Makino M. An in vitro model of Mycobacterium leprae induced granuloma formation. BMC Infect. Dis. 13, 279–2334–13–279 (2013). • First study to describe the creation of an in vitro dormancy model of Mtb infection. This is a key breakthrough in the understanding of Mtb pathophysiology.
  Google Scholar
• 133 Braian C, Svensson M, Brighenti S, Lerm M, Parasa VR. A 3D human lung tissue model for functional studies on Mycobacterium tuberculosis infection. J. Vis. Exp. 104, doi:10.3791/53084 (2015).
  MedlineGoogle Scholar
• 134 Hudock TA, Lackner AA, Kaushal D. Microdissection approaches in tuberculosis research. J. Med. Primatol. 43(5), 294–297 (2014). • This manuscript identifies how microdissection may become a more useful tool in studying Mtb infections in a variety of models.
  MedlineGoogle Scholar
• 135 Seimon TA, Kim MJ, Blumenthal A et al. Induction of ER stress in macrophages of tuberculosis granulomas. PLoS ONE 5(9), e12772 (2010).
  MedlineGoogle Scholar
• 136 Bergeron A, Bonay M, Kambouchner M et al. Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. J. Immunol. 159(6), 3034–3043 (1997).
  Medline CASGoogle Scholar
• 137 Schauf V, Rom WN, Smith KA et al. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J. Infect. Dis. 168(4), 1056–1059 (1993).
  Medline CASGoogle Scholar
• 138 Law K, Weiden M, Harkin T, Tchou-Wong K, Chi C, Rom WN. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153(2), 799–804 (1996).
  Medline CASGoogle Scholar
• 139 Tsao TC, Hong J, Huang C, Yang P, Liao SK, Chang KS. Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis. Tuber. Lung Dis. 79(5), 279–285 (1999).
  Medline CASGoogle Scholar
• 140 Nau GJ, Guilfoile P, Chupp GL et al. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc. Natl Acad. Sci. USA 94(12), 6414–6419 (1997).
  Medline CASGoogle Scholar